• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    Alexion Pharmaceuticals, Inc. (ALXN)

    -NasdaqGS
    180.37 Down 2.74(1.50%) Feb 27, 4:00PM EST
    |After Hours : 178.21 Down 2.16 (1.20%) Feb 27, 5:03PM EST
    Add to Portfolio
    Prev Close:183.11
    Open:183.08
    Bid:0.00 x 100
    Ask:184.89 x 200
    1y Target Est:214.41
    Beta:1.4
    Earnings Date:Apr 22 - Apr 27 (Est.)
    Day's Range:179.44 - 183.99
    52wk Range:136.37 - 203.30
    Volume:944,706
    Avg Vol (3m):1,266,780
    Market Cap:36.46B
    P/E (ttm):55.33
    EPS (ttm):3.26
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ALXN

    Comparison

    Symbol% ChgMkt Cap
    ALXNDown 1.50%36.46B
    AMGNDown 0.79%119.69B
    BAXUp 0.70%37.52B

    Key Statistics

    Forward P/E (1 yr):24.64
    P/S (ttm):16.57
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :5.91
    Quarterly EPS Est (Mar-15) :1.33
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):1.21

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. It offers Soliris (eculizumab), a therapeutic product to treat paroxysmal nocturnal hemoglobinuria (PNH), a genetic blo... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback